Robotic Surgery Staging for Endometrial Cancer Patients
Studies robotic surgery with the da Vinci SP system in adults with endometrial cancer.
Plain-language title generated from the registry record
Registry title: Application of da Vinci SP for Endometrial Cancer Surgical Staging
Key facts
- Where
- Milan, Naples, and Roma, ItalySee the 3 sites
Where in Italy
- IEO Istituto Europeo di OncologiaMilan, ItalyTaking people
- Istituto Nazionale Tumori Fondazione PascaleNaples, ItalyTaking people
- Istituti Fisioterapici Ospitalieri (IFO)Roma, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Cancer Institute, Naples
- Trial code
- NCT07027046
- Record updated
- 19 September 2025
- Original description
Prospective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.Read full original descriptionShow less
Application of da Vinci SP for Endometrial Cancer Surgical Staging: a Prospective Multicenter Study
Prospective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.
Inclusion: Age ≥ 18 years; Histologically confirmed endometrial carcinoma (including uterine carcinosarcoma); Performance status (ECOG) 0 - 1; Patients undergoing staging surgery for endometrial cancer, including but not limited to robotic hysterectomy with bilateral salpingo-oophorectomy (ovarian preservation in selected patients is not an exclusion criterion) and possible sentinel lymph node biopsy/pelvic ± para-aortic lymphadenectomy; Signed informed consent to participate in the study.
Exclusion: Patients scheduled for an additional extra-genital surgical procedure during the staging surgery for endometrial carcinoma; Any reason that may interfere with regular follow-up, even if limited to the first 30 days post-surgery; Dementia or significantly altered mental status that may impair understanding and the ability to provide informed consent; Patients with anesthesiological contraindications to a minimally invasive approach; Synchronous tumor; Recurrence of endometrial carcinoma.